CTLA4 and cancer: Instead of focusing on individual cancer types, this strategy identifies common features, such as altered receptor expression (e.g., PD-L1, CTLA-4), metabolic changes (including glutaminase activity), extracellular matrix remodeling (collagen or hyaluronan), and variations in membrane lipid composition.